After successful roll out of NDAMIS system for managing most business processes, we are happy to introduce MM payment scheme
NDA launching an awareness campaign against buying medicines from hawkers
Today, NDA takes on another phase of raising awareness of dangers of buying medicine from hawkers by placing stickers on the emergency window of commuter taxis that operate around Kampala and those plying along Jinja-Mbale Road.
Hawking of medicine is illegal and whoever is doing so is fleecing the unsuspecting public of their hard earned income for no health benefits.
STRICTLY BUY DRUGS FROM OUTLETS LICENSED BY NATIONAL DRUG AUTHOURITY
NDA INTRODUCES MOBILE MONEY PAYMENT SCHEME FOR NDAMIS GENERATED INVOICES
ISO/IEC 17025:2017 ACCREDITATION
National Drug Quality Control Laboratory is ISO/IEC 17025:2017 Accredited
ISO/IEC 17025:2017 ACCREDITATION PAGE 2
National Drug Quality Control Laboratory is ISO/IEC 17025:2017 Accredited
ISO/IEC 17025:2017 ACCREDITATION PAGE 3
National Drug Quality Control Laboratory is ISO/IEC 17025:2017 Accredited
ISO 9001:2015 CERTIFICATION
National Drug Authority is ISO 9001:2015 Certified
NATIONAL DRUG AUTHORITY QUALITY POLICY
National Drug Authority (NDA) is committed to providing the highest standard of drug regulatory service to all customers.
* Click on the link to download
- Requirement for a Pharmacovigilance system for licensed persons in Uganda
- Provisions for emergency importation of Remdesivir in the context of the COVID-19 Pandemic
- Extension of the deadline for submission of CTD dossiers for renewal of registration
- Retention of products for the financial year 2020 / 2021
- Analysis for Nitrosamine impurities in drugs
- Public Warning : Adulterated & substandard herbal products on the market – Embaluka hardcore drink & Megapower
- Circular on falsified chloroquine products circulating in Africa
- Circular on falsified Human Immunodeficiency Virus (HIV) Uni-Gold test kits
- Circular on Importation of personal protective equipment
- Circular on Importation, Exportation & sale of Chloroquine & Hydroxychloroquine
- Caution against stockpiling and irrational use of medicine
- Communication circular on Clinical Trial new format for CT certificates
* Click on the link to download
- Veterinary Medicines Updates Bulletin Issue 5 June 2020
- Pharmacovigilance Bulletin June 2020
- Product applications with incomplete submission recommended for dismissal
- NDA PV bulletin Volume 11, issue 4 December 2019
- ADR Report - October - December 2019
- Pharmacovigilance Bulletin September 2019
- NDA PV bulletin June 2019
- NDA-PV bulletin - April 2019
- Frequently Asked Questions about National Drug Authority
- NDA-PV bulletin-Jan 2018
- Signed Joint Communique
- Stepwise guide for Product retention on NDAMIS.
* Click on the link to download
- Public notice on tested hand sanitizers as at September 15th 2020 (updated)
- Public notice on tested hand sanitizers as at June 8th 2020 (updated)
- Public notice on tested hand sanitizers as at May 15th 2020
- Public Warning : Adulterated & substandard herbal products on the market – Embaluka hardcore drink & Megapower
- Public notice on Authorized sanitizers April 2020
POPULAR STORIES
NDA engagement meeting with National Drug Shops Advocacy Initiative Executive
Discussions included areas of cooperation to improve compliance of health service delivery
Veterinary Drugs
For guaranteed animal safety, health and production.
Use Veterinary Drugs responsibly
LATEST NEWS
Get the very latest happening at the Uganda National Drug Authority daily
A team of stakeholders attending an NDA research dissemination meeting on ceftriaxone and fluoroquinolone use in health facilities in Uganda.
Dr. Victoria Nambasa- Manager Pharmacovigilance giving her presentation. The commissioner Health Services Pharmaceuticals and Natural medicines Dr. Neville O. Oteba…
NDA launching an awareness campaign against buying medicines from hawkers
Today, NDA takes on another phase of raising awareness of dangers of buying medicine from hawkers by placing stickers on…
NDA Adverse Drug Reporting System
Pharmacovigilance in general if done poorly, adversely affects the quality, safety and efficacy of drugs as well as public health in general
